Raymond James Financial
WVE icon

Raymond James Financial’s Wave Life Sciences WVE Stock Holding History

Raymond James Financial’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,000
Closed -$50K – 5463
2025
Q4 		$50K Buy
+10,000
New +$102K ﹤0.01% 5008

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Raymond James Financial's WVE Position: Q2 2026 in Review

Raymond James Financial increased its Wave Life Sciences (WVE) stake by 12% in Q2 2026, buying an estimated $32.1K and bringing the position to 44,459 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #4912.

Raymond James Financial first reported a position in WVE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.89M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Raymond James Financial held 44,459 shares of Wave Life Sciences worth $258K as of Q2 2026.
  • Raymond James Financial bought 4,834 Wave Life Sciences shares in Q2 2026, an estimated $32.1K.
  • Wave Life Sciences made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4912 holding.
  • Raymond James Financial first reported a position in Wave Life Sciences in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Wave Life Sciences position peaked at $1.89M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.